The West Greenwich offices of Amgen Inc. may have a more genuine core of employee satisfaction than other businesses, just based on what it does. The Thousand Oaks, Calif.-based company makes medications that help people feel better.
Richard A. Andrews recently was appointed chief operating officer at ProThera Biologics in Providence, a company that is developing inter-alpha inhibitor proteins to treat severe inflammation associated with infection, trauma and disease. He discussed his new role at the company with Providence Business News, as well as his past experience.
Could Providence be the next Cambridge, a city known as a biotechnology hub? Given recent economic-development activity, it would seem that this corner of the technology sector is on the verge of a takeoff.
Since CV Properties LLC and …
A five-year, $11.5 million grant from the National Institutes of Health will allow Brown University to launch the Center for Biomedical Research Excellence to study cancer, preeclampsia and severe lung infections.
Edward Bozzi, associate professor and coordinator of the University of Rhode Island Biotechnology Program, talked about Rhode Island BioScience Leaders, the organization that he helped found three years ago, with Providence Business News.